NextPlat
NextPlat
NXPL
NASDAQ
1.01
USD
0.00%
About
NextPlat Corp is a global e-commerce and healthcare company. Its e-Commerce Operations segment involves acquiring and leasing, an e-commerce platform to collaborate with businesses to optimize their ability to sell their goods online, domestically, and internationally, and enabling customers and partners to optimize their e-commerce presence and revenue, and other related businesses.
Its Healthcare Operations segment provides third-party administration, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, compounded medications, tele pharmacy services, anti-retroviral medications, medication therapy management, the supply of prescription medications to long-term care facilities, medication adherence packaging, contracted pharmacy services for 340B covered entities.
It provides Mobile Satellite Services solutions for satellite-enabled voice, data, personnel and asset tracking, Machine-to-Machine and Internet of Things connectivity services..
Financials Amount (in millions)
Income statement
Balance sheet
Cash flow
Ratios
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 57.7K |
| Three Month Average Volume | 2.5M |
| High Low | |
| Fifty-Two Week High | 2.68 USD |
| Fifty-Two Week Low | 0.9857 USD |
| Fifty-Two Week High Date | 12 Apr 2024 |
| Fifty-Two Week Low Date | 14 Aug 2024 |
| Price and Volume | |
| Current Price | 1.175 USD |
| Beta | 1 |
| Relative Price Change | |
| Four Week Relative Price Change | 3.94% |
| Thirteen Week Relative Price Change | -6.17% |
| Twenty-Six Week Relative Price Change | -22.00% |
| Fifty-Two Week Relative Price Change | -59.93% |
| Year-to-Date Relative Price Change | -39.86% |
| Price Change | |
| One Day Price Change | -2.49% |
| Thirteen Week Price Change | 0.43% |
| Twenty-Six Week Price Change | -14.23% |
| Five Day Price Change | -4.47% |
| Fifty-Two Week Price Change | -49.79% |
| Year-to-Date Price Change | -28.79% |
| Month-to-Date Price Change | 4.91% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 1.71881 USD |
| Book Value Per Share (Most Recent Quarter) | 1.3985 USD |
| Tangible Book Value Per Share (Last Fiscal Year) | 0.9095 USD |
| Tangible Book Value Per Share (Most Recent Quarter) | 1.14973 USD |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | -0.20398 USD |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 2.15823 USD |
| Revenue Per Share (Trailing Twelve Months) | 3.46835 USD |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | -99999.99 USD |
| Dividend Per Share (Trailing Twelve Months) | 0 USD |
| Dividend Per Share (5 Year) | -99999.99 USD |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | -0.21596 USD |
| Excluding Extraordinary Items (Trailing Twelve Months) | -0.28196 USD |
| Normalized (Last Fiscal Year) | 0.30136 USD |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | -0.21596 USD |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | -0.26749 USD |
| Including Extraordinary Items (Last Fiscal Year) | -0.21596 USD |
| Including Extraordinary Items (Trailing Twelve Months) | -0.28196 USD |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 1.40494 USD |
| Cash Per Share (Most Recent Quarter) | 1.31117 USD |
| Cash Flow Per Share (Last Fiscal Year) | -1.1552 USD |
| Cash Flow Per Share (Trailing Twelve Months) | -1.41164 USD |
| Free Cash Flow Per Share (Trailing Twelve Months) | -0.07011 USD |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | -21 |
| Cash Flow Revenue (Trailing Twelve Months) | -2 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | -46.16% |
| Pretax Margin (Last Fiscal Year) | -59.04% |
| Pretax Margin (5 Year) | -63.43% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 29.96% |
| Gross Margin (Trailing Twelve Months) | 30.81% |
| Gross Margin (5 Year) | 26.33% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | -61.60% |
| Operating Margin (Trailing Twelve Months) | -47.29% |
| Operating Margin (5 Year) | -57.88% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | -59.11% |
| Net Profit Margin (Trailing Twelve Months) | -46.19% |
| Net Profit Margin (5 Year) | -63.59% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | -56.50% |
| Tangible Book Value (5 Year) | 70.59% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | -99,999.99% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | 474.47% |
| Revenue Growth (3 Year) | 45.82% |
| Revenue Change (Trailing Twelve Months) | 498.54% |
| Revenue Per Share Growth | -65.76% |
| Revenue Growth (5 Year) | 87.92% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | 84.42% |
| Total Debt (5 Year) | -99,999.99% |
| Dividends | |
| Dividend Growth (3 Year) | -99,999.99% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | -17.47% |
| EPS Change (Trailing Twelve Months) | 72.22% |
| EPS Growth (3 Year) | -99,999.99% |
| EPS Growth (5 Year) | -99,999.99% |
| EBITDA | |
| EBITDA (5 Year) | -99,999.99% |
| EBITDA (5 Year Interim) | -99,999.99% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -99,999.99% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 1 |
| Price to Tangible Book (Most Recent Quarter) | 1 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | -100,000 |
| Price to Free Cash Per Share (Trailing Twelve Months) | -100,000 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | -23,539,000 |
| Net Debt (Last Fiscal Year) | -24,761,000 |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 1 |
| Price to Sales (Trailing Twelve Months) | 0 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | -100,000 |
| PE Normalized (Last Fiscal Year) | 4 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | -100,000 |
| PE Including Extraordinary Items (Trailing Twelve Months) | -100,000 |
| Dividends | |
| Dividend Yield (5 Year) | -99,999.99% |
| Dividend Yield | -99,999.99% |
| Current Dividend Yield | 0.00% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 1 |
| Price to Book (Most Recent Quarter) | 1 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 4 |
| Long Term Debt to Equity (Most Recent Quarter) | 4 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | -99,999.99% |
| Payout Ratio (Trailing Twelve Months) | -99,999.99% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 3 |
| Quick Ratio (Most Recent Quarter) | 3 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 3 |
| Current Ratio (Most Recent Quarter) | 3 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | -4,243,000 |
| Free Cash Flow (Trailing Twelve Months) | -1,342,380 |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | -100,000 |
| Net Interest Coverage (Trailing Twelve Months) | -100,000 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 5 |
| Total Debt to Equity (Most Recent Quarter) | 5 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | -47.94% |
| Return on Assets (Trailing Twelve Months) | -74.48% |
| Return on Assets (5 Year) | -49.85% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | -13.04% |
| Return on Equity (Trailing Twelve Months) | -18.35% |
| Return on Equity (5 Year) | -41.10% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | -73.28% |
| Return on Investment (Trailing Twelve Months) | -106.89% |
| Return on Investment (5 Year) | -67.99% |